XML 21 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Cash Flow Statements (Unaudited) - USD ($)
 3 Months Ended
Apr. 03, 2016
Apr. 05, 2015
Cash flows from operating activities:    
Net loss $ (5,099,000) $ (13,033,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,953,000 2,180,000
Stock-based compensation expense 363,000 206,000
Deferred revenue recognized 0 (2,170,000)
Deferred loan costs recognized 205,000 77,000
Gain on the sale of assets (2,370,000) 0
Provision for excess and obsolete inventory 25,000 82,000
Other noncash items 137,000 (183,000)
Contributions to pension plans 0 (77,000)
Changes in operating assets and liabilities:    
Accounts receivable (1,066,000) 17,303,000
Inventory (630,000) (1,047,000)
Other current assets 423,000 (691,000)
Accounts payable (1,048,000) (7,046,000)
Accrued and other liabilities 2,397,000 (916,000)
Net cash used in operating activities (4,710,000) (5,315,000)
Cash flows from investing activities:    
Capital expenditures, net (40,000) (295,000)
Proceeds from sale of assets 11,066,000 0
Change in restricted cash (6,000,000) 0
Net cash provided by (used in) investing activities 5,026,000 (295,000)
Cash flows from financing activities:    
Principal payments on Term Loan (429,000) 0
Proceeds from related party note payable 1,000,000 4,000,000
Net change in debt under New Revolving Credit Agreement 449,000 0
Net change in debt under Credit Facility 0 (1,051,000)
Debt issuance and modification costs (379,000) (440,000)
Indirect repurchase of shares of minimum statutory tax withholdings 0 (77,000)
Cash dividends paid 0 (410,000)
Net cash provided by financing activities 641,000 2,022,000
Net increase (decrease) in cash and cash equivalents 957,000 (3,588,000)
Cash and cash equivalents at beginning of period 1,349,000 7,003,000
Cash and cash equivalents at end of period $ 2,306,000 $ 3,415,000